{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:15:37Z","timestamp":1792721737288,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA048734"],"award-info":[{"award-number":["UG3DA048734"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.psyneuen.2025.107570","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T02:22:21Z","timestamp":1754446941000},"page":"107570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effects of suvorexant on diurnal cortisol and patient-reported stress during opioid withdrawal in a randomized trial"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-2201","authenticated-orcid":false,"given":"Greer","family":"McKendrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Clapham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Zipunnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-5461","authenticated-orcid":false,"given":"Eric C.","family":"Strain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wolinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8073-7701","authenticated-orcid":false,"given":"Andrew S.","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.psyneuen.2025.107570_bib1","first-page":"1","article-title":"The visual analogue scale: An easy and reliable way of assessing perceived stress","volume":"1","author":"Barr\u00e9","year":"2017","journal-title":"Quality in Primary Health Care"},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107570_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/13556210020040235","article-title":"Salivary cortisol during opiate dependence and withdrawal","volume":"6","author":"Bearn","year":"2001","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107570_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/ADM.0000000000000087","article-title":"Possible evidence for re-regulation of HPA axis and brain reward systems over time in treatment in prescription opioid-dependent patients","volume":"9","author":"Bunce","year":"2015","journal-title":"J. Addict. Med."},{"issue":"8","key":"10.1016\/j.psyneuen.2025.107570_bib4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1360-0443.1992.tb02001.x","article-title":"Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts","volume":"87","author":"Cam\u00ed","year":"1992","journal-title":"Br. J. Addict."},{"issue":"5","key":"10.1016\/j.psyneuen.2025.107570_bib5","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/s41380-022-01501-1","article-title":"Corticosteroid sensitization drives opioid addiction","volume":"27","author":"Carmack","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.psyneuen.2025.107570_bib6","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.psyneuen.2013.05.003","article-title":"A day-centered approach to modeling cortisol: diurnal cortisol profiles and their associations among US adults","volume":"38","author":"Dmitrieva","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.psyneuen.2025.107570_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2215-0366(24)00068-3","article-title":"Establishing a research agenda for the study and assessment of opioid withdrawal","volume":"11","author":"Dunn","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"10.1016\/j.psyneuen.2025.107570_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biopsych.2011.05.015","article-title":"Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals","volume":"70","author":"Fatseas","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107570_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12946","article-title":"Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system","volume":"26","author":"Fragale","year":"2021","journal-title":"Addict. Biol."},{"issue":"5","key":"10.1016\/j.psyneuen.2025.107570_bib10","first-page":"261","article-title":"Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits","volume":"18","author":"Gerra","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107570_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.psyneuen.2025.107570_bib12","article-title":"The orexin neurotransmitter system as a target for medication development for opioid use disorder","author":"Huhn","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"650","key":"10.1016\/j.psyneuen.2025.107570_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn8238","article-title":"Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper","volume":"14","author":"Huhn","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.psyneuen.2025.107570_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/7854_2016_56","article-title":"Role of the orexin\/hypocretin system in stress-related psychiatric disorders","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.psyneuen.2025.107570_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A decade of orexin\/hypocretin and addiction: where are we now?","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.psyneuen.2025.107570_bib16","first-page":"11","article-title":"A role for brain stress systems in addiction","volume":"59","author":"Koob","year":"2008"},{"key":"10.1016\/j.psyneuen.2025.107570_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2008.07.043","article-title":"Neurobiological substrates for the dark side of compulsivity in addiction","volume":"56","author":"Koob","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2025.107570_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fpsyt.2013.00072","article-title":"Addiction is a reward deficit and stress surfeit disorder","volume":"4","author":"Koob","year":"2013","journal-title":"Front. Psychiatry"},{"issue":"6","key":"10.1016\/j.psyneuen.2025.107570_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/occmed\/kqr037","article-title":"Validity of occupational stress assessment using a visual analogue scale","volume":"61","author":"Lesage","year":"2011","journal-title":"Occupational medicine"},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107570_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/00952990802013664","article-title":"Serum cortisol secretion during heroin abstinence is elevated only nocturnally","volume":"34","author":"Li","year":"2008","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.psyneuen.2025.107570_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijpsycho.2005.10.007","article-title":"Cortisol secretion patterns in addiction and addiction risk","volume":"59","author":"Lovallo","year":"2006","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.psyneuen.2025.107570_bib22","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-clinpsy-081423-023518","article-title":"Treating opioid use disorder and opioid withdrawal in the context of fentanyl","volume":"21","author":"Martinez","year":"2025","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107570_bib23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/jcem.86.2.7233","article-title":"Orexin a stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade","volume":"86","author":"Mazzocchi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.psyneuen.2025.107570_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.tins.2021.09.002","article-title":"Orexin (hypocretin) and addiction","volume":"44","author":"Mehr","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.psyneuen.2025.107570_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108931","article-title":"Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatment","volume":"227","author":"Mukherjee","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107570_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1300\/J069v25n02_02","article-title":"Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts","volume":"25","author":"Nava","year":"2006","journal-title":"J. Addict. Dis."},{"issue":"15","key":"10.1016\/j.psyneuen.2025.107570_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf0364","article-title":"Cues conditioned to withdrawal and negative reinforcement: neglected but key motivational elements driving opioid addiction","volume":"7","author":"Pantazis","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.psyneuen.2025.107570_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/jcpt.13114","article-title":"Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management","volume":"45","author":"Pergolizzi","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.psyneuen.2025.107570_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsae025","article-title":"Suvorexant alters dynamics of the sleep-electroencephalography-power spectrum and depressive-symptom trajectories during inpatient opioid withdrawal","volume":"47","author":"Reid","year":"2024","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.psyneuen.2025.107570_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12160-015-9753-9","article-title":"Use of salivary diurnal cortisol as an outcome measure in randomised controlled trials: a systematic review","volume":"50","author":"Ryan","year":"2016","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.psyneuen.2025.107570_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2020.102074","article-title":"Alteration of orexin-A and PKC\u03b1 in the postmortem brain of pure-opioid and multi-drug abusers","volume":"83","author":"Sadat-Shirazi","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.psyneuen.2025.107570_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2018.09.034","article-title":"The role of the orexin system in stress response","volume":"154","author":"Sargin","year":"2019","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.psyneuen.2025.107570_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/00952990902933878","article-title":"Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts","volume":"35","author":"Shi","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"16","key":"10.1016\/j.psyneuen.2025.107570_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172883","article-title":"Stress and substance use disorders: risk, relapse, and treatment outcomes","volume":"134","author":"Sinha","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107570_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/pr.58.1.4","article-title":"Orexins in the regulation of the hypothalamic-pituitary-adrenal axis","volume":"58","author":"Spinazzi","year":"2006","journal-title":"Pharm. Rev."},{"issue":"6","key":"10.1016\/j.psyneuen.2025.107570_bib36","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1210\/jc.2004-2385","article-title":"Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells","volume":"90","author":"Spinazzi","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"447","key":"10.1016\/j.psyneuen.2025.107570_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4953","article-title":"Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy","volume":"10","author":"Thannickal","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.psyneuen.2025.107570_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.101","article-title":"Effects of cortisol administration on craving in heroin addicts","volume":"5","author":"Walter","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.psyneuen.2025.107570_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1369-1600.2010.00205.x","article-title":"Heroin reduces startle and cortisol response in opioidmaintained heroin-dependent patients","volume":"16","author":"Walter","year":"2011","journal-title":"Addict. Biol."},{"issue":"4","key":"10.1016\/j.psyneuen.2025.107570_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/10253890.2014.930432","article-title":"Associations of hair cortisol concentration with self-reported measures of stress and mental health-related factors in a pooled database of diverse community samples","volume":"17","author":"Wells","year":"2014","journal-title":"Stress"},{"issue":"6","key":"10.1016\/j.psyneuen.2025.107570_bib41","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/00952990802385781","article-title":"Dysfunction of the hypothalamic-pituitary-adrenal axis in opioid dependent subjects: effects of acute and protracted abstinence","volume":"34","author":"Zhang","year":"2008","journal-title":"Am. J. Drug Alcohol Abuse"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453025002938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453025002938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:45:40Z","timestamp":1772804740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453025002938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0306453025002938"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2025.107570","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of suvorexant on diurnal cortisol and patient-reported stress during opioid withdrawal in a randomized trial","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2025.107570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107570"}}